GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Materialise
Who Owns Materialise?
Understanding Materialise's ownership is key to its strategic direction in 3D printing. Its 2014 IPO on NASDAQ changed its ownership structure significantly.
Founded in 1990 by Wilfried Vancraen and Hilde Ingelaere, Materialise NV has grown into a leader in additive manufacturing software and medical 3D printing services.
Who owns Materialise?
Materialise NV, a pioneer in 3D printing software and services, was founded by Wilfried Vancraen and Hilde Ingelaere in June 1990. The company's journey into public ownership began with its Initial Public Offering (IPO) on NASDAQ on June 25, 2014, which raised approximately $100 million. This transition from a private to a public entity meant that ownership became distributed among public shareholders, institutional investors, and potentially still includes significant stakes held by the founders and early stakeholders. As of July 2025, the company's market capitalization was approximately $541 million. The company's offerings include solutions like the Materialise BCG Matrix, which aids in strategic product portfolio analysis.
Who Founded Materialise?
Materialise NV was established in June 1990 by Wilfried Vancraen and his wife, Hilde Ingelaere. Wilfried Vancraen, who continues to serve as CEO, spearheaded the company's inception, drawing from research conducted at the University of Leuven. The company's initial focus was as a rapid prototyping service bureau, acquiring its first Stereolithography machine and becoming a pioneer in the Benelux region.
The founders envisioned leveraging 3D printing for diverse applications. Their early work focused on digital mapping of human anatomy and developing industrial software solutions.
Materialise began as a rapid prototyping service bureau with a single Stereolithography machine. Initial operations were supported by limited seed funding, typical for university spin-offs.
Key early developments included the Mimics medical image processing software in 1992 and the industrial software solution, Magics. These were later commercialized to drive growth.
While specific early equity splits are not publicly detailed, the founders' foundational role established their significant control and vision for the company's strategic direction.
The company was the first of its kind in the Benelux region to operate a Stereolithography machine. This positioned them as early leaders in additive manufacturing.
The founding team's vision for applying 3D printing technology across medical and industrial sectors was evident in their early product development and strategic decisions.
The early ownership structure of Materialise NV was primarily defined by its founders, Wilfried Vancraen and Hilde Ingelaere. Their foundational role in establishing the company in June 1990, stemming from research at the University of Leuven, naturally placed them in a position of significant control. While precise initial equity percentages are not publicly disclosed, their vision guided the company's early trajectory, which included pioneering additive manufacturing services in the Benelux region and developing crucial software like Mimics and Magics. This early focus on both service and software development laid the groundwork for the company's future growth and its position in the market. Understanding this foundational ownership is key to grasping the company's Mission, Vision & Core Values of Materialise.
Complete Materialise Strategy Bundle
- 6 Full Frameworks, 1 Company – All Pre-Researched
- Each Framework Fully Sourced with Real Company Data
- Built for Strategy Courses, Case Studies & MBA Programs
- Adapt to Your Assignment – No Starting from Scratch
- 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's
How Has Materialise’s Ownership Changed Over Time?
Materialise's journey as a publicly traded entity began on June 25, 2014, with its listing on the NASDAQ Global Select Market under the ticker 'MTLS'. This initial public offering, priced at $12 per American Depositary Share (ADS), successfully raised approximately $96 million. This capital infusion was instrumental in fueling the company's expansion in services and software development, significantly impacting its ownership structure.
| Ownership Type | Percentage (as of March 28, 2025) | Key Holders |
|---|---|---|
| Insider Ownership | 58.60% | Board of Directors and Senior Management |
| Institutional Ownership | 15.34% | Disciplined Growth Investors, Inc., Luther King Capital Management Corp. |
| Float Shares | 55.93 million | Publicly available for trading |
Following its public debut, Materialise's ownership has diversified to include a mix of institutional investors, mutual funds, index funds, and individual insiders. As of March 28, 2025, a significant portion, approximately 58.60% of the outstanding ordinary shares, is beneficially owned by members of the board of directors and senior management, indicating strong insider control. Key institutional shareholders, such as Disciplined Growth Investors, Inc. and Luther King Capital Management Corp., also hold substantial stakes. By July 2025, the company had 55.93 million shares in float, with institutional ownership accounting for 15.34%. The market capitalization of Materialise NV was around $0.30 billion USD in July 2025, with some sources citing approximately $541 million. Strategic acquisitions, like OrthoView in 2014 and ACTech Holding GmbH in 2017, have further solidified its market position and influenced its overall company structure.
Materialise's ownership structure reflects a blend of insider and institutional investment following its 2014 IPO.
- The company is publicly traded on the NASDAQ Global Select Market.
- Insider ownership is substantial, held by the board and senior management.
- Key institutional investors play a significant role in Materialise company ownership.
- Understanding these stakeholders is crucial for analyzing Materialise company financial ownership details.
- The Marketing Strategy of Materialise is also influenced by its ownership landscape.
From PESTLE Factors to Full Strategy Bundle
- PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
- Every Strategic Angle Covered – Nothing Left to Research
- Pre-filled with Company-Specific Research
- No Missing Sections for Your Case Study
- One Download Covers Your Entire Company Analysis
Who Sits on Materialise’s Board?
The current board of directors for Materialise NV is instrumental in guiding the company's strategic direction and governance, reflecting its ownership landscape. As of June 3, 2025, shareholders re-elected key individuals to the board, including Mr. Wilfried Vancraen, Mr. Peter Leys, Ms. Hilde Ingelaere, and Mr. Jurgen Ingels, to serve until the next Annual General Shareholders' Meeting. Other members include A TRE C CVOA, represented by Mr. Johan De Lille, Ms. Marleen Mannekens, and Ms. Godelieve Verplancke. Mr. Wilfried Vancraen holds the position of Founder and Executive Chairman, while Ms. Brigitte de Vet-Veithen serves as the Chief Executive Officer.
| Director Name | Position | Affiliation/Representation |
|---|---|---|
| Mr. Wilfried Vancraen | Founder and Executive Chairman | |
| Ms. Brigitte de Vet-Veithen | Chief Executive Officer | |
| Mr. Peter Leys | Director | |
| Ms. Hilde Ingelaere | Director | |
| Mr. Jurgen Ingels | Director | |
| Mr. Johan De Lille | Director | A TRE C CVOA |
| Ms. Marleen Mannekens | Director | |
| Ms. Godelieve Verplancke | Director |
Materialise NV operates under a voting structure typical for a publicly traded entity on NASDAQ, adhering to a one-share-one-vote principle for its American Depositary Shares (ADSs), where each ADS represents one ordinary share. This structure means that significant voting power resides with those holding substantial equity. As of March 28, 2025, members of the board and senior management collectively beneficially owned approximately 58.60% of the outstanding shares. This substantial ownership stake grants them considerable influence over critical decisions, including the election of board members and the approval of corporate actions such as dividend policies and mergers. There are no publicly disclosed instances of dual-class shares, golden shares, or specific founder shares that would confer disproportionate voting rights beyond their equity holdings. The company's governance appears stable, with no major reported proxy battles or activist investor campaigns disrupting its operations. Recent shareholder meetings, such as the Annual General Shareholders' Meeting on June 3, 2025, have seen the approval of resolutions including the Belgian GAAP statutory annual accounts for fiscal year 2024 and amendments to the articles of association to renew the Board of Directors' authorization to increase authorized capital, indicating a smooth and consistent shareholder engagement process. Understanding the Brief History of Materialise can provide further context on its ownership evolution.
Materialise's ownership is significantly influenced by its board and senior management, who hold a majority stake. This concentration of ownership suggests a stable governance environment.
- Board and senior management beneficially own 58.60% of outstanding shares as of March 28, 2025.
- The company follows a one-share-one-vote principle for its ADSs.
- No dual-class shares or special voting rights beyond equity ownership have been publicly reported.
- Recent shareholder meetings confirm a stable approval process for corporate actions.
Materialise Business Model + Strategy Bundle
- Ideal for Essays, Case Studies & Slides
- Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
- Company-Specific Content Already Organized
- One Bundle Replaces Days of Independent Research
- Buy the Bundle Once. Use Across All Your Assignments
What Recent Changes Have Shaped Materialise’s Ownership Landscape?
Over the past few years, Materialise NV has experienced revenue growth, particularly in its Medical segment, while navigating market uncertainties. The company's ownership structure remains influenced by institutional investors, with a focus on sustainable growth and innovation.
| Financial Year | Total Revenue (kEUR) | Materialise Medical Revenue Growth | Net Profit (kEUR) | Diluted EPS (EUR) |
| 2023 | 256,127 | N/A | 6,695 | 0.11 |
| 2024 | 266,765 | 14.8% | 13,406 | 0.23 |
Materialise's financial performance in 2024 showed a positive trajectory with a 4.2% increase in total revenue, driven significantly by its Medical segment's 14.8% growth. This upward trend continued into the first quarter of 2025, with total revenue rising by 4.3% and the Medical segment seeing an impressive 18.7% increase. However, the second quarter of 2025 experienced a slight dip in consolidated revenue by 5.8% compared to the previous year, though the Medical segment maintained strong momentum with 16.7% growth. The company's net profit saw a substantial jump in 2024 to 13,406 kEUR, more than doubling from 6,695 kEUR in 2023, reflecting improved profitability. While there haven't been major share buybacks or new offerings announced in 2024-2025, Materialise continues its strategic investments in research and development, particularly within its Medical and Software divisions. The company's leadership includes CEO Brigitte de Vet-Veithen and Founder and Executive Chairman Wilfried Vancraen. Industry trends suggest a growing presence of institutional ownership in the additive manufacturing sector, with Materialise reporting 15.34% institutional ownership as of July 2025. Despite geopolitical and macroeconomic challenges, Materialise has adjusted its full-year 2025 revenue guidance to a range of 265,000 to 280,000 kEUR, underscoring its commitment to robust business fundamentals and sustainable expansion, as detailed in its 2024 Sustainability Report. Understanding the Revenue Streams & Business Model of Materialise provides further insight into the company's operational strategy.
Materialise NV is a publicly traded company, with its ownership primarily distributed among institutional investors and public shareholders. The company's structure is designed to support its ongoing innovation and market expansion.
Wilfried Vancraen, the founder, holds a significant position as Executive Chairman, while Brigitte de Vet-Veithen leads as Chief Executive Officer. Institutional investors represent a notable portion of Materialise company stock ownership.
In 2024, Materialise reported a net profit of 13,406 kEUR, a substantial increase from the previous year. The company's revenue growth, especially in its Medical segment, highlights its operational strengths.
The company has provided a revenue guidance for fiscal year 2025, anticipating between 265,000 to 280,000 kEUR. This outlook reflects a cautious yet optimistic approach to market conditions.
From Five Forces to Full Company Analysis
- Includes SWOT, PESTLE, BMC, BCG and 4P's
- Pre-Researched with Company-Specific Data
- Best Value for a Complete Analysis
- Ready to Adapt for Your Case Study
- Ready for Essays and Slidesd
- What is Brief History of Materialise Company?
- What is Competitive Landscape of Materialise Company?
- What is Growth Strategy and Future Prospects of Materialise Company?
- How Does Materialise Company Work?
- What is Sales and Marketing Strategy of Materialise Company?
- What are Mission Vision & Core Values of Materialise Company?
- What is Customer Demographics and Target Market of Materialise Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.